JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
JPMorgan BetaBuilders Europe ETF
BBEU
|
+$5.47B |
| 2 |
iShares 0-1 Year Treasury Bond ETF
SHV
|
+$3.17B |
| 3 |
State Street Financial Select Sector SPDR ETF
XLF
|
+$2.05B |
| 4 |
Amazon
AMZN
|
+$1.96B |
| 5 |
Meta Platforms (Facebook)
META
|
+$1.6B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$1.72B |
| 2 |
Vanguard Intermediate-Term Treasury ETF
VGIT
|
+$1.31B |
| 3 |
UnitedHealth
UNH
|
+$1.26B |
| 4 |
Automatic Data Processing
ADP
|
+$1.17B |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$1.08B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 27.28% |
| 2 | Technology | 17.17% |
| 3 | Healthcare | 10.79% |
| 4 | Financials | 9.36% |
| 5 | Consumer Discretionary | 8.67% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
3426
State Street SPDR Nuveen ICE Short Term Municipal Bond ETF
SHM
$3.46B
| $1.88M | ﹤0.01% |
39,584
+284
| +0.7% | +$13.4K |
2013 Q2
39 quarters
|
|
3427
Invesco S&P 500 Quality ETF
SPHQ
$18.9B
| $1.88M | ﹤0.01% |
39,760
+5,703
| +17% | +$261K |
2022 Q1
4 quarters
|
|
3428
MaxCyte
MXCT
$109M
| $1.88M | ﹤0.01% |
379,855
+73,298
| +24% | +$361K |
2021 Q3
6 quarters
|
|
3429
Pathward Financial
CASH
$1.49B
| $1.88M | ﹤0.01% |
45,278
-113,294
| -71% | -$5.34M |
2015 Q2
31 quarters
|
|
3430
GrafTech
EAF
$231M
| $1.87M | ﹤0.01% |
38,450
+7,108
| +23% | +$385K |
2018 Q2
19 quarters
|
|
|
MCHB
3431
Mechanics Bancorp
MCHB
$3.24B
| $1.86M | ﹤0.01% |
103,617
-50,777
| -33% | -$1.27M |
2013 Q2
39 quarters
|
|
|
ABCM
3432
DELISTED
Abcam PLC
ABCM
| $1.86M | ﹤0.01% |
138,412
+16,875
| +14% | +$252K |
2021 Q4
5 quarters
|
|
3433
CALL
Accenture
ACN
$120B
| $1.86M | ﹤0.01% |
6,500
-4,500
| -41% | -$1.23M |
2021 Q2
7 quarters
|
|
3434
Pediatrix Medical
MD
$2.12B
| $1.86M | ﹤0.01% |
124,531
+20,166
| +19% | +$305K |
2013 Q2
39 quarters
|
|
3435
PUT
Vir Biotechnology
VIR
$1.97B
| $1.86M | ﹤0.01% |
+79,800
| New | +$2.04M |
2023 Q1
0 quarters
|
|
3436
ProShares Ultra VIX Short-Term Futures ETF
UVXY
$252M
| $1.85M | ﹤0.01% |
1,595
+429
| +37% | +$574K |
2022 Q4
1 quarter
|
|
|
BCYC
3437
Bicycle Therapeutics
BCYC
$266M
| $1.85M | ﹤0.01% |
87,138
+3,932
| +5% | +$98.6K |
2021 Q1
8 quarters
|
|
3438
OneSpaWorld
OSW
$2.33B
| $1.85M | ﹤0.01% |
154,631
+88,558
| +134% | +$965K |
2019 Q2
15 quarters
|
|
3439
PUT
Unisys
UIS
$167M
| $1.85M | ﹤0.01% |
477,200
+342,100
| +253% | +$1.65M |
2022 Q4
1 quarter
|
|
3440
iShares US Basic Materials ETF
IYM
$1.27B
| $1.85M | ﹤0.01% |
13,963
+5,588
| +67% | +$743K |
2020 Q4
9 quarters
|
|
|
OPTU
3441
Optimum Communications Inc
OPTU
$374M
| $1.85M | ﹤0.01% |
540,569
-391,237
| -42% | -$1.66M |
2017 Q2
23 quarters
|
|
3442
Opko Health
OPK
$1.04B
| $1.85M | ﹤0.01% |
1,265,200
-13,618
| -1% | -$17.5K |
2015 Q3
30 quarters
|
|
3443
Telkom Indonesia
TLK
$12.8B
| $1.84M | ﹤0.01% |
67,395
+12,466
| +23% | +$321K |
2013 Q2
39 quarters
|
|
3444
Astec Industries
ASTE
$891M
| $1.84M | ﹤0.01% |
44,538
+9,378
| +27% | +$396K |
2016 Q4
25 quarters
|
|
3445
Upwork
UPWK
$1.05B
| $1.84M | ﹤0.01% |
162,164
-317,012
| -66% | -$3.77M |
2018 Q4
17 quarters
|
|
|
KAMN
3446
DELISTED
Kaman Corp
KAMN
| $1.83M | ﹤0.01% |
80,326
+2,283
| +3% | +$54.3K |
2015 Q4
29 quarters
|
|
3447
Compass Diversified
CODI
$816M
| $1.83M | ﹤0.01% |
95,992
-53,769
| -36% | -$1.1M |
2015 Q4
29 quarters
|
|
3448
Cannae Holdings
CNNE
$670M
| $1.83M | ﹤0.01% |
90,633
+17,027
| +23% | +$377K |
2017 Q4
21 quarters
|
|
3449
Beyond Meat
BYND
$130M
| $1.82M | ﹤0.01% |
3,745
+368
| +11% | +$182K |
2019 Q2
15 quarters
|
|
3450
iShares US Financials ETF
IYF
$3.75B
| $1.82M | ﹤0.01% |
25,560
-12
| -0% | -$923 |
2013 Q2
39 quarters
|
|
Similar funds
JP Morgan Chase's Q1 2023 Portfolio in Review
As of Q1 2023, JP Morgan Chase held 7,579 positions worth $821B, up 8.2% from $759B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
JP Morgan Chase's Q1 2023 filing shows 751 new, 3,314 increased, 2,056 reduced and 652 closed positions. Its largest new stake was Near Intelligence, Inc. Common Stock: 5,852,099 shares worth $14.7M. The largest sale was Eli Lilly, an estimated $1.72B.
By sector, the portfolio is most concentrated in Miscellaneous at 27% of assets, up from 27% a quarter earlier, followed by Technology and Healthcare.
- JP Morgan Chase's largest Q1 2023 buy was Near Intelligence, Inc. Common Stock: 5,852,099 shares worth $14.7M.
- JP Morgan Chase added most to JPMorgan BetaBuilders Europe ETF in Q1 2023, an estimated $5.47B increase.
- JP Morgan Chase's biggest Q1 2023 reduction was Eli Lilly, cutting an estimated $1.72B.
- JP Morgan Chase fully exited IAA, Inc. Common Stock in Q1 2023, selling an estimated $155M.
- JP Morgan Chase's ten largest holdings make up 17% of its $821B portfolio in Q1 2023.
- JP Morgan Chase opened 751 new positions and closed 652 in Q1 2023.
- JP Morgan Chase's portfolio value rose 8.2% quarter-over-quarter to $821B.
Based on JP Morgan Chase's 13F filing for Q1 2023, filed 11 May 2023.